Hot Dow Dividend Companies To Buy For 2014

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, toy-maker Hasbro (NASDAQ: HAS  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Hasbro, and see what CAPS investors are saying about the stock right now.

Hasbro facts

�

�

Headquarters (founded)

Pawtucket, R.I. (1923)

Market Cap

$6.2 billion

Industry

Leisure products

Trailing-12-Month Revenue

Top 5 Building Product Companies To Own For 2015: Red Fork Energy Ltd (RDFEY)

Red Fork Energy Limited is an independent oil and gas exploration and production company focused in the midcontinent of the United States. The Company�� Big River project is exploiting the oil and liquids rich gas bearing Mississippi limestone formation (the Mississippi Play). The Company�� East Oklahoma project is located east of Tulsa in Oklahoma. The Company�� subsidiaries include Red Fork (USA) Investments, Inc. and EastOK Pipeline LLC. Advisors' Opinion:

• [By Sally Jones] urrent RDFEY share price is 3.69, or 53.6% off the 52-week high of $7.95.

  Down 49% over 12 months, RDFEY has a market cap of $164.78 million, and trades at a P/B of 1.40.

  Red Fork Energy Limited is engaged in shale gas and oil exploration and production in USA. Red Fork Energy has a large landholding in Oklahoma with producing oil and gas fields, as well as highly prospective development acreage. The company has positioned itself in a premier on-shore, horizontal oil resource play, with a large and growing position in the Mississippi Lime oil and gas play.

  The company reported second quarter 2013 financial results with record sales of $6.985 million for the quarter, representing a 72.5%% increase from the previous quarter. The company had record gross production of 174.8 million barrels oil equivalents, a 33.4% increase from the previous quarter.

  Revenue and net income tracking:

Hot Dow Dividend Companies To Buy For 2014: Morgan Stanley China A Share Fund Inc.(CAF)

Morgan Stanley China A Share Fund, Inc. is a closed-ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. It is co-managed by Morgan Stanley Investment Management Company. The fund invests in the public equity markets of China. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the growth stocks of companies. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Morgan Stanley Capital International China A Share Index. Morgan Stanley China A Share Fund, Inc. was formed on July 6, 2006 and is domiciled in the United States.

Advisors' Opinion:

• [By pamatlarge]

  As the Chinese economy slows down, investors can profit by shorting a long ETF that holds Chinese stocks in major industries. The iShares China Large-Cap ETF (FXI) has a market cap of $5.12 billion and is among the most heavily traded ETFs. The ETF concentrates its holdings in financial services, communication services and technology. The SPDR China ETF (GXC) is another large-cap ETF that is heavily invested in Chinese financial service companies and technology companies. The Morgan Stanley China A Share Fund (CAF) has a much smaller market cap of $474 million. This ETF invests in a broad range of industries including Chinese commercial banks, insurance companies and pharmaceutical companies. Holding a short position with these ETFs could pay off when one or more sections hits a downturn.

Hot Dow Dividend Companies To Buy For 2014: Camden Property Trust (CPT)

Camden Property Trust is a real estate investment trust (REIT). The Company is engaged in the ownership, management, development, acquisition, and construction of multi-family apartment communities. As each of its communities has similar economic characteristics, residents, amenities, and services, its operations have been aggregated into one segment.

In April 2011, it sold one of its land parcels to one of the Funds. In June 2011, it sold another land parcel to the Fund. In August 2011, the Company acquired 30.1 acres of land located in Atlanta, Georgia. In December 2011, it acquired 2.2 acres of land in Glendale, California. During the year ended December 31, 2011, it sold two properties consisting of 788 units located in Dallas, Texas. During 2011, the Funds acquired 18 multifamily properties totaling 6,076 units located in the Houston, Dallas, Austin, San Antonio, Tampa and Atlanta. In January 2012, one of the Funds acquired one multifamily property consisted of 350 units located in Raleigh, North Carolina.

As of December 31, 2011, the Company owned interests in, operated, or were developing 206 multifamily properties comprising 69,794 apartment homes across the United States. Of these 206 properties, 10 properties were under development. In addition, it owns land parcels, which it focuses on developing into multifamily apartment communities.

Advisors' Opinion:

• [By Michael Lewis]

  Take Camden Property Trust (NYSE: CPT  ) , for example. The stock is up around 16% over two years -- respectable, but incongruent with the industry trends. Since 2010, operating cash flow has increased more than 30%. The company pays a 3.5% dividend and trades at 16.5 times projected one-year earnings. For comparison, Lennar trades at 18 times earnings, while KB Homes trades at more than 20 times forward earnings.

Hot Dow Dividend Companies To Buy For 2014: Sky Deutschland AG (SKYD)

Sky Deutschland AG is a Germany-based holding company, which operates a subscription television network in Germany and Austria. The Company manages television brands, including Sky Welt and Sky Welt Extra, as well as offers packages Film, Sport, Fussball Bundesliga (Germany football league), and HD (High Definition television), as well as pay-per-view service Sky Select and Sky Go. Furthermore, the Company offers Sky Hotel & Bars service, which provides the Company's services in public houses and bars. The Company offers approximately 70 television channels of various genres. Sky Select package enables watching selected movies at the specific time. Sky Go offers content on mobile devices, Internet and simultaneously on different television sets. The Company is also engaged in the purchase, sale and distribution of rights to film, series and television productions, the acquisition, sale and distribution of broadcasting rights for public events, among others. Advisors' Opinion:

• [By Inyoung Hwang]

  Sky Deutschland AG (SKYD) surged 5 percent to 7.55 euros, the highest price since September 2008. The pay-television said third-quarter ebitda climbed 19 percent to 29.2 million euros. Revenue jumped 19 percent from a year earlier to 392.7 million, topping analysts��estimates.

Hot Dow Dividend Companies To Buy For 2014: Insmed Inc.(INSM)

Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.

Advisors' Opinion:

• [By Brian Pacampara]

  What: Shares of biotechnology company Insmed (NASDAQ: INSM  ) plunged 15% today after a phase 3 trial of the company's experimental lung-infection drug Arikace disappointed Wall Street. �

• [By John Kell var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

  Insmed Inc.(INSM) said its lead product candidate–an inhaled antibiotic to treat serious lung infections–missed its primary goals in a Phase II study of patients with hard-to-treat cases of nontuberculous mycobacterial lung infections. The product candidate, called Arikayce, didn’t produce statistically significant improvement in the levels of mycobacterial density. Shares dropped 10% to $16.39 premarket.

• [By Eric Volkman]

  Insmed (NASDAQ: INSM  ) will have nearly $60 million at its disposal if a new public stock offering goes as planned. The company is floating 6 million shares of its common stock in a public issue that has been priced at $10.40 per share. The gross take will be $62.4 million, which the firm said should net it around $58 million after fees and expenses.

• [By Jake L'Ecuyer]

  Insmed Incorporated (NASDAQ: INSM) was on the rise as well, gaining 7.68 percent to $14.10 after the company announced some positive phase 2 clinical trial results in a study evaluating its drug Arikayce.

Hot Dow Dividend Companies To Buy For 2014: MutualFirst Financial Inc.(MFSF)

MutualFirst Financial, Inc. operates as a holding company for MutualBank that provides financial products services to individuals and businesses. It accepts various savings deposit accounts, NOW and demand accounts, and certificates of deposit. The company also provides one- to four-family residential mortgage loans, multi-family and commercial real estate loans, construction and development loans, commercial business loans, and consumer loans, including home equity and lines of credit, home improvement, auto, boat, and recreational vehicle loans, as well as loans secured by savings deposits, and credit card and unsecured loans. In addition, it operates as an insurance agent and sells life insurance, and credit-life and health insurance products. Further, the company provides investment money management and trust services. It operates 33 full service financial centers located in Delaware, Elkhart, Grant, Kosciusko, Randolph, St. Joseph, and Wabash counties, Indiana. The co mpany was founded in 1889 and is headquartered in Muncie, Indiana.

Advisors' Opinion:

• [By Tim Melvin]

  MutualFirst Financial (MFSF) makes the list, trading at 80% of book value and yielding 1.61%. The bank has total assets of about $1.4 billion and is located in Muncie, Ind. Like a lot of small banks today, the story here is one of steady credit improvement and compressed net interest margins. It is one of many smaller institutions that I think will eventually be taken over; the current regulatory climate simply does not favor little banks. Insiders own about 10% of the stock, so they are invested in the idea of a much higher stock price.

Hot Dow Dividend Companies To Buy For 2014: AspenBio Pharma Inc.(APPY)

AspenBio Pharma, Inc. operates as an emerging biomedical company focused on obtaining the United States FDA clearance for its lead product, AppyScore. Its research and development activities primarily focus on a human appendicitis blood-based test. The company?s lead product candidate, AppyScore, is a blood-based diagnostic test to help physicians manage patients who enter emergency rooms complaining of abdominal pain and suspected of having acute appendicitis. It is also developing animal healthcare products focusing on reproduction. The company was formerly known as AspenBio, Inc. and changed its name to AspenBio Pharma, Inc. on September 26, 2005. AspenBio Pharma, Inc. was founded in 2000 and is based in Castle Rock, Colorado.

Advisors' Opinion:

• [By James E. Brumley]

  To tell the truth, I'm not the least bit surprised that I'm chiming in on Venaxis Inc. (NASDAQ:APPY) today. It was a stock I dissected just two days ago (on Tuesday - here's that chat), pointing out how all the telltale signs of bullishness were brewing. Sure enough, APPY popped on Wednesday, and as a result has gone from a mere potential big mover to an actual mover.

• [By Bryan Murphy]

  If you're reading this, then odds are you know that Venaxis Inc. (NASDAQ:APPY) shares are up a solid 10% today, while the market as a whole is in the red. What you may not know about APPY, however, is that with today's strength, the stock has worked its way past a big hurdle and put itself into a situation where more upside is very likely.

• [By Lee Jackson]

  Vernaxis Inc. (NASDAQ: APPY) is an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE MarkedAPPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis. They have moved ahead with their pivotal trial enrollment, and the analyst at Canaccord Genuity rates the company as a stock to buy. Its price target for the stock is a whopping $7, the high target for the stock. A move to that level would represent a 250% move for shareholders. The consensus target is at $5.25.�Vernaxis closed Friday at $1.97.